Short answer · Medically reviewed summary · Last updated: 2026-05-08
Chronic Granulomatous Disease (CGD) is primarily diagnosed using functional assays, such as the Dihydrorhodamine (DHR) flow cytometry test, which measures the ability of white blood cells to produce reactive oxygen species. Confirmation is subsequently achieved through genetic testing to identify mutations in the genes responsible for the NADPH oxidase complex, such as CYPBB or NCF1. How is Chronic Granulomatous Disease diagnosed? The diagnostic process for Chronic Granulomatous Disease often begins when a patient presents with recurrent, severe bacterial or fungal infections.
2 people with Chronic Granulomatous Disease have shared their first-person experience on this question at DiseaseMaps.
How is Chronic Granulomatous Disease diagnosed?
How Chronic Granulomatous Disease is diagnosed: tests, specialists and the diagnostic journey, told by patients and reviewed against medical sources.
Chronic Granulomatous Disease (CGD) is primarily diagnosed using functional assays, such as the Dihydrorhodamine (DHR) flow cytometry test, which measures the ability of white blood cells to produce reactive oxygen species. Confirmation is subsequently achieved through genetic testing to identify mutations in the genes responsible for the NADPH oxidase complex, such as CYPBB or NCF1.
How is Chronic Granulomatous Disease diagnosed?
The diagnostic process for Chronic Granulomatous Disease often begins when a patient presents with recurrent, severe bacterial or fungal infections. Because Chronic Granulomatous Disease is rare, patients often experience a "diagnostic odyssey," spending months or years undergoing tests for unrelated conditions before an immunologist identifies the underlying defect in phagocyte function.
What tests are used to identify Chronic Granulomatous Disease?
Clinicians utilize a specific sequence of testing to confirm the diagnosis:
- DHR Flow Cytometry: The gold standard screening test that measures the oxidative burst of neutrophils.
- Genetic Sequencing: Analysis of the genes associated with Chronic Granulomatous Disease (CYBB, CYBA, NCF1, NCF2, or NCF4) to confirm the specific inheritance pattern.
- Biopsies: If granulomas are present in the lungs or gastrointestinal tract, tissue samples may be taken to confirm the characteristic inflammatory response associated with Chronic Granulomatous Disease.
Which specialists should be involved?
Diagnosis is typically managed by a clinical immunologist or an infectious disease specialist. It is vital to consult these specialists early, as Chronic Granulomatous Disease can be confused with other primary immunodeficiencies, inflammatory bowel disease (Crohn's-like symptoms), or chronic infections. If your primary care provider is unfamiliar with the condition, seeking a referral to a center of excellence is essential for accurate, timely testing.
Next steps
- Consult a board-certified clinical immunologist for specialized testing.
- Connect with the 60 members of the Chronic Granulomatous Disease community at DiseaseMaps.org for peer support.
- Request a genetic counseling session to understand the inheritance risks for family members.
Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment.
References
- NIH Genetic and Rare Diseases Information Center (GARD): Chronic Granulomatous Disease.
- Orphanet: Rare Disease Database (ORPHA:217).
- OMIM (Online Mendelian Inheritance in Man): Entry #306400.
- Immune Deficiency Foundation (IDF): Educational resources on CGD.
Posted Dec 24, 2017 by carrie123 3550
Posted Jul 23, 2018 by Wanderer 400
